Share on StockTwits

Shares of Alere (NYSE:ALR) were down 14.2% during trading on Monday after the company announced weaker than expected quarterly earnings, reports. The company traded as low as $34.26 and last traded at $34.28, with a volume of 3,135,272 shares trading hands. The stock had previously closed at $39.95.

The company reported $0.42 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.58 by $0.16. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $747.55 million. During the same quarter last year, the company posted $0.64 earnings per share. Alere’s revenue was down 3.4% compared to the same quarter last year.

A number of analysts have recently weighed in on ALR shares. Analysts at Zacks upgraded shares of Alere from an “underperform” rating to a “neutral” rating in a research note on Thursday, July 10th. They now have a $38.70 price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Alere from $45.00 to $50.00 in a research note on Thursday, July 10th. They now have a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $44.12.

The stock has a 50-day moving average of $38.13 and a 200-day moving average of $36.43. The company’s market cap is $2.825 billion.

Alere Inc is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.